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Abstract: This study examined the pathological changes in tissues and organs with acute intoxications with amitraz and its veterinary
medicinal formulation. In total 312 healthy white English mice (Mus musculus), 156 female and 156 male, were used for this
purpose. The solutions were given to the mice by gavage at the following dosages: 500, 1000, 1500, 1800, 2200 or 2500 mg of
technical amitraz/kg and 50, 100, 250, 500, 750 or 1000 mg of amitraz/kg in a veterinary formulation. There was an interval of
1 week after the administration of the study medication. Necropsies were performed immediately on the mice that died during this
period and after 7 days on the surviving mice and those in the control group after ether euthanasia. The body weights and liver and
kidney weights of all mice were determined.
It was observed that amitraz was metabolised in a high degree in the liver, and xylene that was added to the formulations was
eliminated from the kidneys and increased the toxicity of amitraz. It was concluded that amitraz caused weight loss in mice.
Key Words: Amitraz, mice, toxicity, pathology

Farelerde Akut Amitraz Zehirlenmelerinde Patolojik Bulgular
Özet: Bu çal›flmada amitraz ve ticari veteriner müstahzar› ile farelerde akut zehirlenme durumlar›nda doku ve organlardaki
hispatolojik bulgular ortaya konulmufltur. Yar›s› erkek ve yar›s› difli 312 adet sa¤l›kl› beyaz ‹ngiliz ›rk› fareye amitraz müstahzar› 50,
100, 250, 500, 750 and 1000 mg/kg ve teknik amitraz 500, 1000, 1500, 1800, 2200 and 2500 mg/kg dozlarda a¤›zdan tek
sefer verilmifltir. Bir hafta içinde ölen farelerde hemen, ölmeyenler ve kontrol grubundakilerde ötanazi uygulanarak ölüm a¤›rl›klar›,
karaci¤er ve böbrek a¤›rl›klar› belirlenmifltir. Ayr›ca, karaci¤er ve böbreklerde de histopatolojik inceleme yap›lm›flt›r.
Çal›flma sonucunda tek dozda bile amitraz›n farelerde kilo kayb›na yol açt›¤› ve ksilenin amitraz›n zehirlili¤ini art›rd›¤›, karaci¤er ve
böbrek a¤›rl›klar›n› de¤ifltirmedi¤i ortaya konulmufltur.
Anahtar Sözcükler: Amitraz, fare, zehirlenme patoloji

Introduction
Amitraz is the common name for N-N-di-(2,4-xylyliminomethyl) methylamine, a formamidine pesticide
currently marketed worldwide as an acaricide, larvicide
and insecticide for use against a variety of plant and
animal pests (1). This pesticide is especially effective
against ticks in cattle and against lice and mange in sheep
and dogs. Furthermore, it is also effective against Varroa
jacobsoni Oudemans, which is the agent of varroa
diseases in bees. Although this compound has been used

in veterinary practice for a long time, few studies have
been conducted on its toxicity (2).
Amitraz is well absorbed when administered orally or
applied as a bath on the skin; therefore, there is a high
risk of toxicity (3-5). After absorption, symptoms such as
depression and sedation in the central nervous system,
bradycardia, decreases in body temperature and blood
pressure, bloating, decreases in gastrointestinal motility
and slowing of the passage of chyme, polyuria, vomiting,
anorexia, mydriasis and hyperglycaemia may occur (6-9).
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It is known that many pesticides are formulised with
organic solvents. Xylene is used in formulising amitraz.
Therefore, xylene should also be taken into consideration
in cases of intoxications with commercial products of
amitraz. Depression in the central nervous system, ataxia,
weakness in the motor functions, muscle twitching in the
eyes, blurring of consciousness, coma and nervous
irritation of unknown origin are seen in acute intoxication
with xylene, which is an aromatic hydrocarbon (10,11).
In fact, in the intoxication cases reported by Bonsall and
Turnbull (12) xylene was demonstrated to be a more
toxic compound in the formulation than amitraz.

Colon: DB WAX colon, 30 m x 0.32 mm, film
thickness 0.5 µm
Oven and injection port temperature: 250 °C
Carrier gas: Nitrogen, 1 ml/min
The solutions of the medicinal product were prepared
based on a 120 mg/ml amitraz concentration. Solutions
of the medicinal product were given to the mice via a
gastric tube in single 1-time doses (Table 1).
Table 1. Animal groups and doses of amitraz solutions.
Animal Groups

No study has been conducted so far to demonstrate
the pathological changes that may occur in organs and
tissues in cases of acute intoxication with amitraz and its
commercial products. The aim of the present study was
to demonstrate the pathological changes in tissues and
organs in cases of acute intoxication with amitraz and its
veterinary medicinal product.

Group 1
(Control)

-

-

2A

500

Group 2

2B

1000

(Technical

2C

1500

Amitraz)

2D

1800

2E

2200

2F

2500

Materials and Methods
Animals
This study was conducted on 312 healthy white
English mice (Mus musculus) (156 male, 156 female).
After 12 male and 12 female mice were identified as the
control group (Group 1), the remaining animals were
divided into 2 main groups each containing 72 female and
72 male mice (Groups 2 and 3), which were then divided
into 12 subgroups each containing 12 female and 12
male mice (Table 1).

Group 3

50

3B

100

3C

250

Medicinal

3D

500

formulation)

3E

750

3F

1000

n = 24

Histopathological examination

Technical amitraz standard* (97%) and veterinary
medicinal product containing 120 mg of amitraz in 1 ml
[Kenecid EC** (12.5% amitraz, 57.5% xylene and 30%
soya oil plus emulgator) formulation was approved by the
Ankara University, Faculty of Veterinary Medicine,
Department of Pharmacology and Toxicology according
to the gas chromatography results] were used in this
study. These were diluted with dimethylsulphoxide to
administer 0.3 ml to each mouse.
Gas Chromatography working conditions

Detector: Nitrogen Phosphorus Detector (NPD),
Temperature 250 °C
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3A
(Veterinary

Medication

* Atabay Drug Ltd. Company, Turkey

Doses, mg/kg

There was an interval of 1 week after the
administration of the medication. Necropsies were
performed immediately on the mice that died during this
period and after 7 days on the surviving mice and those
in the control group after euthanasia using ether. Body
weight after death and the weights of liver and kidneys of
all mice were calculated. The kidneys and a sample slice
from the liver were fixed in buffered 10% formaldehyde
solution. Paraffin blocks were prepared after passing
through ethyl alcohol and xylol stages. Slices of 5-6
micron thickness were cut by a microtome and stained
with haematoxylin-eosin and examined under a light
microscope.

** Tay Drug Ltd. Company, Turkey
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Statistical analysis
The statistical significance was assessed using oneway ANOVA followed by the Newman-Keuls multiple
comparison test (13).

Results
Following amitraz administration, deaths started to
occur on day 3 in Group 2B, in the 6th h in Group 2C, in
the 2nd h in Group 2D, in the 1st h in Group 2E and in the
45th min in Group 2F; all of the mice in Group 2F died
within 6 h. After the administration of the veterinary
medicinal formulation deaths started to occur in the 18th
h in Group 3B, in the 4th h in Group 3C, in the 2nd h in
Group 3D, in the 1st h in Group 3E and in the 30th min in
Group 3F and ended on the 4th day. No deaths were
observed in Groups 2A or 3A.
During necropsies of the mice that died a
subcutaneous fluid collection and loss of hair related to
this in Group 2 and a green coloration in both the
subcutis and other tissues were observed in Group 3.
Mice from both groups had distension due to gaseous
collection in the stomach and intestines. In Groups 2C,
2D, 2E and 2F, an off-white coloration in some lobes of

the liver was observed and no gross pathological findings
were found in the kidneys. While Groups 3A and 3B did
not have any gross change in their livers and kidneys,
there was an off-white coloration in some lobes of the
livers of mice from other groups and especially a white,
localised region in the left renal pelvis (a lighter coloration
in the right kidney). At the end of the 7th day, surviving
mice from Groups 2A, 2B, 2C, 2D, 2E-female, 3A, 3B,
3C, 3D and 3E-male and the control group were
sacrificed by ether euthanasia and similar findings were
found in mice from Groups 2C, 2D, 2E-female, 3C, 3D
and 3E-male. Body weights (Table 2) and liver and kidney
weights (Table 3) of all the groups were determined.
The body weights of Group 1 mice sacrificed by
euthanasia at the end of the 7th day (WMAD) were slightly
higher than their body weights measured on the 1st day
(WMA), while there was a significant weight loss in
Groups 2A, 2B, 2C, 2D, 2E (only females), 3A, 3B and 3C
(P < 0.05). There was no significant difference between
the body weights in groups 2E-males, 3D, 3E and 3F
between the 1st and 7th days (P > 0.05).
Liver and kidney weights (g) of mice measured after
death due to the agent or euthanasia are presented in
Table 3.

Table 2. Body weights (g) of mice measured alive, before the agent was administered and measured after death due to the drug or euthanasia.
Male
Group

WMA1

Female
WMAD2

WMA1

WMAD2

1

24.01 ± 3.1

25.11 ± 3.8

22.10 ± 3.2

23.04 ± 2.9

2A

25.80 ± 2.3

21.20 ± 2.9*

26.30 ± 1.8

21.10 ± 3.2*

2B

24.30 ± 2.5

20.10 ± 3.3*

25.40 ± 2.7

19.80 ± 2.4*

2C

26.60 ± 3.1

21.10 ± 2.9*

24.40 ± 1.8

18.10 ± 3.4*

2D

25.40 ± 2.9

17.80 ± 3.6*

28.10 ± 3.9

19.10 ± 3.1*

2E

27.50 ± 3.2

25.20 ± 3.8

26.90 ± 2.2

20.10 ± 3.1*

2F

28.10 ± 3.4

27.20 ± 3.1

27.30 ± 2.8

26.10 ± 3.1

3A

26.80 ± 3.2

22.3 ± 4.0*

27.60 ± 2.8

22.20 ± 3.9*

3B

25.30 ± 2.4

21.30 ± 4.6*

28.10 ± 3.3

22.50 ± 4.9*

3C

24.60 ± 1.7

21.20 ± 2.4*

24.90 ± 2.1

21.30 ± 3.9*

3D

25.60 ± 2.4

24.50 ± 2.8

25.90 ± 2.5

24.70 ± 3.0

3E

28.40 ± 3.6

27.70 ± 3.4

26.60 ± 2.9

25.20 ± 3.2

3F

27.8 0± 3.1

27.10 ± 3.4

27.70 ± 3.2

27.50 ± 3.4

1.Weight measured alive (g), 2. Weight measured after death (g), *.P < 0.05
n = 24
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Table 3. Liver and kidney weights (g) of mice measured after death due to the agent or euthanasia.
Liver
Group
1
2A
2B
2C
2D
2E
2F
3A
3B
3C
3D
3E
3F

Male
2.01
2.11
2.19
2.04
2.14
2.07
2.09
1.98
2.08
2.10
2.07
2.08
2.02

±
±
±
±
±
±
±
±
±
±
±
±
±

0.26
0.31
0.28
0.19
0.18
0.24
0.18
0.23
0.31
0.33
0.28
0.20
0.27

Kidney
Female
1.92
1.99
2.10
2.02
2.01
1.98
2.03
2.05
2.06
1.99
2.03
2.00
2.04

±
±
±
±
±
±
±
±
±
±
±
±
±

0.21
0.20
0.19
0.22
0.19
0.24
0.28
0.17
0.20
0.19
0.31
0.24
0.30

Male
0.38
0.36
0.36
0.37
0.37
0.40
0.36
0.40
0.39
0.36
0.38
0.37
0.36

±
±
±
±
±
±
±
±
±
±
±
±
±

0.07
0.02
0.06
0.09
0.06
0.10
0.08
0.09
0.10
0.06
0.11
0.08
0.10

Female
0.35
0.38
0.34
0.39
0.38
0.35
0.37
0.39
0.39
0.36
0.34
0.35
0.37

±
±
±
±
±
±
±
±
±
±
±
±
±

0.06
0.09
0.04
0.08
0.07
0.04
0.08
0.12
0.13
0.09
0.09
0.10
0.11

n = 24

There was a slight increase in the liver weights of the
mice exposed to either study agent, but the difference did
not attain statistical significance (P > 0.05). There were
no differences in the weights of the kidneys between the
groups.
No pathological changes were detected in the kidneys
of Group 2 and the livers of the Groups 2A and 2B, while

degenerative changes were detected in the groups
exposed to doses of 1500 mg/kg and over (2C, 2D, 2E
and 2F) in the histopathological examination of livers.
Hydropic degeneration in the hepatocytes of the liver in
Group 2C, and fatty changes as well as hydropic
degeneration were observed in the livers of Group 2D.
Liver degeneration was severe in Groups 2E and 2F
(Figure 1). Similar findings were observed in the animals

Figure 1. Vacuolar degeneration and fatty changes in liver epithelial cells. H&E. Bar, 50 µm.
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exposed to doses of 250 mg/kg and over in Group 3.
Hydropic degeneration in the liver in Group 3C, and
hydropic degeneration and fatty liver were observed in
Groups 3D, 3E and 3F. Tubulonephrosis in the kidneys of
Group 3D and necrosis in the tubulus epithelial cells of the
kidneys of Groups 3E and 3F were observed. The tubular
basal membranes of the kidneys were intact (Figure 2).

Discussion
In acute intoxication induced with technical amitraz
standard and its veterinary product, the difference
between the body weights of mice measured on the 1st
day when alive and those measured after death was
significant (P < 0.05) in Groups 2A, 2B, 2C, 2D, 2E (only
females), 3A, 3B and 3C and was not significant (P >
0.05) in the others. Amitraz is therefore thought to
stimulate α2-adrenergic receptors (14), which induce
bloating and constipation (15), causing a decrease in
appetite and resulting in weight loss. The absence of
weight loss in some groups can be explained by death
occurring on the day following the administration of the
study agent, thereby limiting the time for a loss in
weight.

When the liver and kidney weights were compared,
there was no significant difference between the mice that
were exposed to the veterinary medicinal product and
technical amitraz and the control animals (P > 0.05).
However, there was an increase in liver weights, albeit
small.
No pathological changes were observed in the kidneys
of mice exposed to technical amitraz standard, but as the
dose proportionally increased severe hydropic
degeneration and fatty changes in the livers were
observed. It was reported that amitraz converted quickly
into a more toxic substance called mono-N-methyl
derivative in the stomach contents after being given
orally. This substance is metabolised in the liver mainly to
4-amino-3-benzoic acid, which is not toxic, and then
eliminated by urine and bile (5). When the liver is exposed
to this substance in an amount above which it cannot be
detoxified, a disturbance results. Furthermore , it was
reported that the conversion of amitraz after being
administered orally to mono-N-benzoic derivative quickly
shows that the stasis in the digestive tract is actually a
result of this metabolite and it plays an important role in
amitraz intoxication (16).

Figure 2. Degeneration and necrosis in tubulus epithelial cells of the kidney. H&E. Bar, 50 µm.
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Lesions that are directly proportional to the dose
given result in lesions in the livers and kidneys of mice
exposed to veterinary medicinal formulation. This shows
that xylene and other substances that are put in the
formulation with amitraz are more toxic than amitraz and
also have adverse affects on the kidneys. It is known that
the carrier substances (soy oil and emulgator) are not
toxic. Ninety-five percent of the absorbed amount of
xylene is eliminated in the urine and less than 5% is
eliminated in unchanged form by way of the lungs (11).
Thus, lesions in the kidneys result from xylene, and
lesions in the livers result mainly from amitraz. Hydropic
degeneration and fatty changes in the hepatocytes of the
liver are common changes in toxic material intake (17).

For this reason, no specific change due to amitraz could
be detected.
Another interesting point is that liver lesions were
seen in animals given technical amitraz standard at doses
of 1500 mg/kg and higher, while liver lesions were seen
in animals given veterinary medicinal formulation at doses
of 250 mg/kg and higher. As pointed in another study
(15), xylene probably causes the amplification of the
intoxication by increasing the absorption of amitraz.
In conclusion, it is observed that amitraz is
metabolised in a high degree in the liver and xylene added
to the formulations is eliminated from the kidneys and
increases the toxicity of amitraz. It is also concluded that
amitraz causes weight loss in mice.
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